CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 163 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2022. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $3,038,000 | -78.0% | 112,700 | -72.2% | 0.06% | -75.4% |
| Q1 2022 | $13,832,000 | -11.9% | 406,100 | 0.0% | 0.22% | +10.9% |
| Q4 2021 | $15,692,000 | -29.8% | 406,100 | -2.0% | 0.20% | -17.9% |
| Q3 2021 | $22,368,000 | +141.3% | 414,300 | -33.7% | 0.25% | +110.3% |
| Q3 2020 | $9,269,000 | +14.1% | 625,000 | 0.0% | 0.12% | +2.6% |
| Q2 2020 | $8,125,000 | – | 625,000 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 1,132,259 | $30,526,000 | 7.80% |
| Ghost Tree Capital, LLC | 400,000 | $10,784,000 | 5.62% |
| Octagon Capital Advisors LP | 761,398 | $20,527,000 | 5.48% |
| VR Adviser, LLC | 865,116 | $23,324,000 | 4.59% |
| ACUTA CAPITAL PARTNERS, LLC | 267,195 | $7,204,000 | 4.01% |
| COMMODORE CAPITAL LP | 538,812 | $14,526,000 | 3.07% |
| Ikarian Capital, LLC | 616,700 | $16,628,000 | 3.03% |
| TSP Capital Management Group, LLC | 266,545 | $7,186,000 | 2.83% |
| Ikarian Capital, LLC | 537,958 | $14,504,000 | 2.64% |
| Ikarian Capital, LLC | 506,500 | $13,656,000 | 2.49% |